[go: up one dir, main page]

GB201709401D0 - Novel use - Google Patents

Novel use

Info

Publication number
GB201709401D0
GB201709401D0 GBGB1709401.2A GB201709401A GB201709401D0 GB 201709401 D0 GB201709401 D0 GB 201709401D0 GB 201709401 A GB201709401 A GB 201709401A GB 201709401 D0 GB201709401 D0 GB 201709401D0
Authority
GB
United Kingdom
Prior art keywords
novel use
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1709401.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idogen AB
Original Assignee
Idogen AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idogen AB filed Critical Idogen AB
Priority to GBGB1709401.2A priority Critical patent/GB201709401D0/en
Publication of GB201709401D0 publication Critical patent/GB201709401D0/en
Priority to EP17758512.2A priority patent/EP3503897A1/en
Priority to PCT/EP2017/071404 priority patent/WO2018037103A1/en
Priority to US16/328,539 priority patent/US20190201431A1/en
Priority to PCT/EP2017/071409 priority patent/WO2018037108A1/en
Ceased legal-status Critical Current

Links

GBGB1709401.2A 2016-08-26 2017-06-13 Novel use Ceased GB201709401D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB1709401.2A GB201709401D0 (en) 2017-06-13 2017-06-13 Novel use
EP17758512.2A EP3503897A1 (en) 2016-08-26 2017-08-25 Ex vivo methods of inducing ido expression in antigen presenting cells using a compound selected from the group consisting of azacytidine, and decitabine
PCT/EP2017/071404 WO2018037103A1 (en) 2016-08-26 2017-08-25 Procainamide for treating immune disorders and for modulating ido expression
US16/328,539 US20190201431A1 (en) 2016-08-26 2017-08-25 Ex vivo methods of inducing ido expression in antigen presenting cells using a compound selected from the group consisting of azacytidine, and decitabine
PCT/EP2017/071409 WO2018037108A1 (en) 2016-08-26 2017-08-25 Ex vivo methods of inducing ido expression in antigen presenting cells using a compound selected from the group consisting of azacytidine, and decitabine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1709401.2A GB201709401D0 (en) 2017-06-13 2017-06-13 Novel use

Publications (1)

Publication Number Publication Date
GB201709401D0 true GB201709401D0 (en) 2017-07-26

Family

ID=59358376

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1709401.2A Ceased GB201709401D0 (en) 2016-08-26 2017-06-13 Novel use

Country Status (1)

Country Link
GB (1) GB201709401D0 (en)

Similar Documents

Publication Publication Date Title
DK3734167T3 (en) Airconditionsystem
GB2566314B (en) Depolarisers
RS61247B1 (en) Diisopentylterephthalate
IL274118A (en) Trifab-contorsbody
GB201818605D0 (en) Nivel use
SG11202002846TA (en) Message-credentialed blockchains
GB202004742D0 (en) Novel use
AU201714106S (en) Mandoline
IL273458A (en) Electrogustometer
GB201613185D0 (en) Novel use
GB201707846D0 (en) Use
GB201714732D0 (en) New Uses
GB201712383D0 (en) Panoxperience
GB201620095D0 (en) Novel use
GB201614590D0 (en) Novel use
DK3351149T3 (en) Syltetøjsfontæne
GB201709401D0 (en) Novel use
GB201709399D0 (en) Novel use
GB201708551D0 (en) Novel use
GB201708503D0 (en) Novel use
GB201718676D0 (en) New use
IL256575A (en) Daburech
GB201720840D0 (en) Balaclavas
GB201718665D0 (en) Uadto
GB201718503D0 (en) Total-bust

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)